38 research outputs found
Nucleotide-Oligomerization-Domain-2 Affects Commensal Gut Microbiota Composition and Intracerebral Immunopathology in Acute Toxoplasma gondii Induced Murine Ileitis
Background Within one week following peroral high dose infection with
Toxoplasma (T.) gondii, susceptible mice develop non-selflimiting acute
ileitis due to an underlying Th1-type immunopathology. The role of the innate
immune receptor nucleotide-oligomerization-domain-2 (NOD2) in mediating
potential extra-intestinal inflammatory sequelae including the brain, however,
has not been investigated so far. Methodology/Principal Findings Following
peroral infection with 100 cysts of T. gondii strain ME49, NOD2-/- mice
displayed more severe ileitis and higher small intestinal parasitic loads as
compared to wildtype (WT) mice. However, systemic (i.e. splenic) levels of
pro-inflammatory cytokines such as TNF-α and IFN-γ were lower in NOD2-/- mice
versus WT controls at day 7 p.i. Given that the immunopathological outcome
might be influenced by the intestinal microbiota composition, which is shaped
by NOD2, we performed a quantitative survey of main intestinal bacterial
groups by 16S rRNA analysis. Interestingly, Bifidobacteria were virtually
absent in NOD2-/- but not WT mice, whereas differences in remaining bacterial
species were rather subtle. Interestingly, more distinct intestinal
inflammation was accompanied by higher bacterial translocation rates to extra-
intestinal tissue sites such as liver, spleen, and kidneys in T. gondii
infected NOD2-/- mice. Strikingly, intracerebral inflammatory foci could be
observed as early as seven days following T. gondii infection irrespective of
the genotype of animals, whereas NOD2-/- mice exhibited higher intracerebral
parasitic loads, higher F4/80 positive macrophage and microglia numbers as
well as higher IFN-γ mRNA expression levels as compared to WT control animals.
Conclusion/Significance NOD2 signaling is involved in protection of mice from
T. gondii induced acute ileitis. The parasite-induced Th1-type immunopathology
at intestinal as well as extra-intestinal sites including the brain is
modulated in a NOD2-dependent manner
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
<p>Abstract</p> <p>Background</p> <p>Previous studies suggest a link between gut microbiota and the development of ulcerative colitis (UC) and irritable bowel syndrome (IBS). Our aim was to investigate any quantitative differences in faecal bacterial compositions in UC and IBS patients compared to healthy controls, and to identify individual bacterial species that contribute to these differences.</p> <p>Methods</p> <p>Faecal microbiota of 13 UC patients, 11 IBS patients and 22 healthy volunteers were analysed by PCR-Denaturing Gradient Gel Electrophoresis (DGGE) using universal and Bacteroides specific primers. The data obtained were normalized using in-house developed statistical method and interrogated by multivariate approaches. The differentiated bands were excised and identified by sequencing the V3 region of the 16S rRNA genes.</p> <p>Results</p> <p>Band profiles revealed that number of predominant faecal bacteria were significantly different between UC, IBS and control group (p < 10<sup>-4</sup>). By assessing the mean band numbers in UC (37 ± 5) and IBS (39 ± 6), compared to the controls (45 ± 3), a significant decrease in bacterial species is suggested (p = 0.01). There were no significant differences between IBS and UC. Biodiversity of the bacterial species was significantly lower in UC (μ = 2.94, σ = 0.29) and IBS patients (μ = 2.90, σ = 0.38) than controls (μ = 3.25, σ = 0.16; p = 0.01). Moreover, similarity indices revealed greater biological variability of predominant bacteria in UC and IBS compared to the controls (median Dice coefficients 76.1% (IQR 70.9 - 83.1), 73.8% (IQR 67.0 - 77.5) and 82.9% (IQR 79.1 - 86.7) respectively). DNA sequencing of discriminating bands suggest that the presence of <it>Bacteroides vulgatus, B. ovatus, B. uniformis</it>, and <it>Parabacteroides sp</it>. in healthy volunteers distinguishes them from IBS and UC patients. DGGE profiles of Bacteroides species revealed a decrease of Bacteroides community in UC relative to IBS and controls.</p> <p>Conclusion</p> <p>Molecular profiling of faecal bacteria revealed abnormalities of intestinal microbiota in UC and IBS patients, while different patterns of Bacteroides species loss in particular, were associated with UC and IBS.</p
Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota
Phenotypic and functional characteristics of intestinal intraepithelial lymphocytes during acute rejection of small intestinal allografts
Human small intestinal mucosa harbours a small population of cytolytically active CD8(+) αβ T lymphocytes
Intraepithelial lymphocytes (IEL) in normal human small intestine exhibit cytotoxicity. This study was undertaken to characterize the effector cells and their mode of action. Freshly isolated jejunal IEL and lamina propria lymphocytes (LPL), as well as IEL and LPL depleted of CD4(+), CD8(+) and T-cell receptor (TCR)-γδ(+) cells were used as effector cells in anti-CD3-mediated redirected cytotoxicity against a murine FcγR-expressing cell line. Effector cell frequencies were estimated by effector to target cell titration and limiting dilution. The capacity of IEL and LPL to kill a Fas-expressing human T-cell line was also analysed. T-cell subsets were analysed for perforin, granzyme B, Fas-ligand (FasL), tumour necrosis factor-α (TNF-α) and TNF-related apoptosis inducing ligand (TRAIL) mRNA expression by reverse transcription–polymerase chain reaction (RT-PCR). Frequencies of IEL expressing the perforin and FasL proteins were determined by immunomorphometry. Both IEL and LPL exhibited significant Ca(2+)-dependent, anti-CD3-mediated cytotoxicity, ≈ 30% specific lysis at the effector to target cell ratio 100. The cytotoxic cells constituted, however, only a small fraction of IEL and LPL (≈ 0·01%). CD8(+) TCR-αβ(+) cells accounted for virtually all the cytotoxicity and expressed mRNA for all five cytotoxic proteins. The frequency of granzyme B-expressing samples was higher in CD8(+) cells than in CD4(+) cells (P<0·05 and <0·01 for IEL and LPL, respectively). In addition, both IEL and LPL exhibited significant spontaneous anti-CD3-independent cytotoxicity against Fas-expressing human T cells. This killing was mediated by Fas–FasL interaction. On average, 2–3% of the IEL expressed perforin and FasL. We speculate that CD8(+) memory cells accumulate in the jejunal mucosa and that the CD8(+) TCR-αβ(+) lymphocytes executing TCR/CD3-mediated, Ca(2+)-dependent cytotoxicity are classical cytotoxic T lymphocytes ‘caught in the act’ of eliminating infected epithelial cells through perforin/granzyme exocytosis. The observed Fas/FasL-mediated cytotoxicity may be a reflection of ongoing down-regulation of local immune responses by ‘activation-induced cell death’
Hysteroscopy During Menopause
Menopause is characterized by permanent cessation of menstrual periods, and clinically defined after 12Â months of complete amenorrhea. It occurs at a median age of 51 alongside with the physiological process of ageing, although it can happen at an earlier age for other medical conditions or after surgery (surgical menopause). Due to reduced estrogen and progesterone levels, reproductive organs undergo progressive atrophy. This reflects also at endometrial level: without the cyclic hormonal actions of the menstrual cycle, the endometrium in menopause becomes atrophic. Nevertheless, many other intrauterine pathologies, such as endometrial or cervical polyps, submucous myomas, and uterine septa, may all be diagnosed during menopause. In addition, the possibility offered by hormone replacement therapy modifies the endometrium, which may proliferate under hormonal stimuli.
In this chapter we report common scenarios observed during hysteroscopy in postmenopausal women, with emphasis on indications, diagnostic/therapeutic role of hysteroscopy when performed during menopause, and limits of the technique
Cytolytic Capabilities of Lamina Propria and Intraepithelial Lymphocytes in Normal and Chronically Inflamed Human Intestine
Walking together: women with the severe symptoms of menopause propose a platform for a walking program; outcome from focus groups
Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel Disease
Metabolomic profiling can be used to study disease-induced changes in inflammatory bowel diseases (IBD). The aim of this study was to investigate the difference in the metabolomic profile of males and females as they developed IBD. Using the IL-10 gene-deficient mouse model of IBD and wild-type mice, urine at age 4, 6, 8, 12, 16, and 20 weeks was collected and analyzed by nuclear magnetic resonance (NMR) spectroscopy. Multivariate data analysis was employed to assess differences in metabolomic profiles that occurred as a consequence of IBD development and severity (at week 20). These changes were contrasted to those that occurred as a consequence of gender. Our results demonstrate that both IL-10 gene-deficient and wild-type mice exhibit gender-related changes in urinary metabolomic profile over time. Some male-female separating metabolites are common to both IL-10 gene-deficient and control wild-type mice and, therefore, appear to be related predominantly to gender maturation. In addition, we were able to identify gender-separating metabolites that are unique for IL-10 gene-deficient and wild-type mice and, therefore, may be indicative of a gender-specific involvement in the development and severity of the intestinal inflammation. The comparison of the gender-separating metabolomic profile from IL-10 gene-deficient mice and wild-type mice during the development of IBD allowed us to identify changes in profile patterns that appear to be imperative in the development of intestinal inflammation, but yet central to gender-related differences in IBD development. The knowledge of metabolomic profile differences by gender and by disease severity has potential clinical implications in the design of both biomarkers of disease as well as the development of optimal therapies